Examining the role of molecular imaging in prostate cancer from staging through biochemical recurrence with Dr. Louis Mazzarelli, Director of Molecular Imaging at Lawrence and Memorial and Westerly Hospitals with Yale New Haven Health.
Ryan Avery, MD
Examining the role of molecular imaging in lung cancer from initial diagnosis through post-therapy follow-up with Dr. Ryan Avery, Associate Professor of Cardiovascular Imaging & Nuclear Medicine, Director of Nuclear Medicine, and Director of Advanced Imaging & Analytics Laboratory in the Department of Radiology at Northwestern Medicine.
Learn more about the features and benefits of Symbia Pro.specta™ SPECT/CT at SNMMI 2022.
Learn more about the features and benefits of Biograph Vision Quadra™ PET/CT at SNMMI 2022.
Joyce van Sluis, MSc. University of Groningen
Laura Whitehouse Dr. Erin Ross Queen Elizabeth Hospital, Birmingham, UK
Highlights from the SNMMI 2022 annual meeting held June 11-14 in Vancouver, BC, Canada.
Prof. Dr Alexander Haug, MD, PhD Division of Nuclear Medicine Medical University of Vienna
Prof. Alban Bailliez, MD, PhD Nuclear Medicine Dept-Humani TEP Faculty of Medicine
Bruce Spottiswoode, PhD
Carl von Gall, MD
Maximizing the clinical impact of receptor imaging in breast cancer
SNMMI 2021 - Symposium
Biograph Vision Quadra first impressions: A quantum leap in PET/CT imaging
SNMMI 2021 - Symposium
Dr. Alin Chirindel, Universitätsspital Basel, Department of Nuclear Medicine in Basel, Switzerland
Expanded SPECT/CT integration into clinical nuclear medicine
Kathryn, Morton, M.D., Professor, University of Utah, Chief, Nuclear Medicine Section, Department of Radiology and Imaging Sciences
Dr. Gary Ulaner, MD, Chair of Molecular Imaging and Therapy, Hoag Family Cancer Institute, Newport Beach, CA USA
